Histamine H1 receptor antagonist

0 marketed 1 in Phase 3 1 in Phase 2

This page covers all Histamine H1 receptor antagonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting H1 receptor, H1-receptor.

Targets

H1 receptor · H1-receptor

Phase 3 pipeline (1)

fexofenadine HCL (M016455) · Sanofi · Allergy
Fexofenadine HCL is an antihistamine that works by blocking the action of histamine, a substance in the body that causes allergy symptoms.

Phase 2 pipeline (1)

Epinastine Nasal Spray · Merck Sharp & Dohme LLC · Respiratory
Epinastine is a selective histamine H1-receptor antagonist that blocks the action of histamine on nasal mucosa, reducing symptoms of allergic rhinitis.